Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Aurobindo Pharma has informed that an analyst / investor call on the Audited Financial Results of the Company for the Year ended 31st March, 2018 is scheduled on 29th May, 2018 at 8:30 AM.
The above information is a part of company’s filings submitted to BSE.